Article Versions Notes

Verzè M, Minari R, Gnetti L, Bordi P, Leonetti A, Cosenza A, Ferri L, Majori M, De Filippo M, Buti S, et al. Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature. Cancers. 2021; 13(21):5403. https://doi.org/10.3390/cancers13215403

Verzè, Michela, Roberta Minari, Letizia Gnetti, Paola Bordi, Alessandro Leonetti, Agnese Cosenza, Leonarda Ferri, Maria Majori, Massimo De Filippo, Sebastiano Buti, and et al. 2021. "Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature" Cancers 13, no. 21: 5403. https://doi.org/10.3390/cancers13215403

Verzè, M., Minari, R., Gnetti, L., Bordi, P., Leonetti, A., Cosenza, A., Ferri, L., Majori, M., De Filippo, M., Buti, S., Gasparro, D., Nizzoli, R., Azzoni, C., Bottarelli, L., Squadrilli, A., Mozzoni, P., & Tiseo, M. (2021). Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature. Cancers, 13(21), 5403. https://doi.org/10.3390/cancers13215403